Mental dysfunction in Parkinson's disease.

The pathological hallmark of Parkinson's disease (PD) is a degeneration of the dopamine (DA) producing cells in the substantia nigra and the ventral tegmentum, resulting in a dopamine deficiency in the dopaminergic projection areas with defective functioning of specific cortico-subcortical extrapyramidal circuits. Depending on which circuits (;motor', ;association' or ;limbic') are involved, and on the extent of the accompanying noradrenergic, serotonergic and cholinergic detrition in PD, dysfunction may result in motor deficits, mood disturbances or cognitive deficits, sometimes proceeding to dementia. Drug-induced psychosis occurs in approximately 15-20% of patients treated with dopaminergic agents. In PD, mainly nigrostriatal dopamine (A9) is depleted, leading to progressive motor dysfunction with subtle cognitive disturbances. As a rule, the neuropsychological deficit in PD might be described as the inability to switch cortical behavioral programmes in situations requiring the internal regulation of behavior. In daily life, in most patients these deficits do not become manifest, due to the abundance of external information to guide behavior. When the ability to use environmental information or external cues is lost as well, significant cell loss in the ventral tegmental area, with reduced DA-innervation of the mesocorticolimbic regions and the nucleus accumbens, must be suspected. This leads to clinically overt defects not only in the ;motor' but also in the ;limbic' and ;association' circuits. In addition to more severe cognitive disturbances or even dementia, this may also lead to mood disorders and drug-induced psychosis. Depression then occurs as the cortical modulation of limbic activity has become deficient, leading to emotional reactions disproportionate to the thoughts that evoke them. The proposed mechanism of psychosis in PD is that cortical sensory input is misinterpreted, leading to misperceptions (hallucinations) or false beliefs about reality due to a reduced ;signal-to-noise' ratio by insufficient processing of relevant information.

[1]  B. Milner Effects of Different Brain Lesions on Card Sorting: The Role of the Frontal Lobes , 1963 .

[2]  J. Cummings,et al.  Depression and Parkinson's disease: a review. , 1992, The American journal of psychiatry.

[3]  T. Svensson,et al.  Mode of Action of Atypical Neuroleptics in Relation to the Phencyclidine Model of Schizophrenia: Role of 5‐HT2 Receptor and &agr;1‐Adrenoreceptor Antagonism , 1995 .

[4]  G. Tollefson,et al.  Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders. , 1997 .

[5]  G. Zubenko,et al.  Endoplasmic Reticulum Abnormality in Alzheimer's Disease: Selective Alteration in Platelet NADH-Cytochrome C Reductase Activity , 1989, Journal of geriatric psychiatry and neurology.

[6]  R. Beninger,et al.  Depressive Symptoms in Parkinson's Disease: A Comparison With Disabled Control Subjects , 1990, Journal of geriatric psychiatry and neurology.

[7]  B. Maccarthy,et al.  Psychiatric morbidity in patients with Parkinson's disease , 1990, Psychological Medicine.

[8]  H. Nelson A Modified Card Sorting Test Sensitive to Frontal Lobe Defects , 1976, Cortex.

[9]  C. Marsden,et al.  HOW COMMON IS DEMENTIA IN PARKINSON'S DISEASE? , 1984, The Lancet.

[10]  John D. E. Gabrieli,et al.  Reduced working memory span in Parkinson's disease: Evidence for the role of frontostriatal system in working and strategic memory. , 1996 .

[11]  A. Lang,et al.  Remoxipride in the treatment of levodopa-induced psychosis. , 1996, Journal of clinical psychopharmacology.

[12]  J. Cummings,et al.  The occurrence of depression in Parkinson's disease. A community-based study. , 1996, Archives of neurology.

[13]  J. Cummings,et al.  Frontal-subcortical circuits and human behavior. , 1993, Journal of psychosomatic research.

[14]  J. Saint-Cyr,et al.  Frontal lobe dysfunction in Parkinson's disease. The cortical focus of neostriatal outflow. , 1986, Brain : a journal of neurology.

[15]  G. Paulson,et al.  The pattern of depressive symptoms varies with progression of Parkinson's disease. , 1990, Journal of neurology, neurosurgery, and psychiatry.

[16]  A. Graybiel The basal ganglia and cognitive pattern generators. , 1997, Schizophrenia bulletin.

[17]  Bernard Pillon,et al.  Cognitive deficits in Parkinson’s disease , 1996, Journal of Neurology.

[18]  M. Piccirilli,et al.  Early frontal impairment as a predictor of dementia in Parkinson's disease , 1997, Neurology.

[19]  R G Robinson,et al.  Depression in Parkinson's Disease , 1990, The Journal of nervous and mental disease.

[20]  L. Brown,et al.  Sensory and cognitive functions of the basal ganglia , 1997, Current Opinion in Neurobiology.

[21]  J. Cummings Behavioral Complications of Drug Treatment of Parkinson's Disease , 1991, Journal of the American Geriatrics Society.

[22]  Eade Oe,et al.  Coeliac lung disease. , 1978, Lancet.

[23]  A. Lieberman Point of view: Dementia in Parkinson's disease. , 1997, Parkinsonism & related disorders.

[24]  D. Kömpf,et al.  A study of visual hallucinations in patients with Parkinson’s disease , 1997, Journal of Neurology.

[25]  G. E. Alexander,et al.  Parallel organization of functionally segregated circuits linking basal ganglia and cortex. , 1986, Annual review of neuroscience.

[26]  K. Marder,et al.  Neuropsychological characteristics of preclinical dementia in Parkinson's disease , 1995, Neurology.

[27]  D. Hannequin,et al.  Clozapine for the treatment of psychosis in Parkinson's disease: a review , 1996, Acta neurologica Scandinavica.

[28]  C. Marsden,et al.  Internal versus external cues and the control of attention in Parkinson's disease. , 1988, Brain : a journal of neurology.

[29]  E. Wolters,et al.  Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson's disease , 1996, Neurology.

[30]  D. Deeg,et al.  Depression in Parkinson's disease. The impact of symptom overlap on prevalence. , 1998, Psychosomatics.

[31]  Antonio R. Damasio,et al.  Towards a neuropathology of emotion and mood , 1997, Nature.

[32]  R. Dolan,et al.  Depression in Parkinson's disease. A positron emission study. , 1994, The British journal of psychiatry : the journal of mental science.

[33]  E. Sullivan,et al.  Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability. , 1991, Brain : a journal of neurology.

[34]  R. Leiguarda,et al.  Cognitive functions in major depression and Parkinson disease. , 1997, Archives of neurology.